Tag: AHA 2026
New data demonstrate etripamil nasal spray can convert recurrent PSVT to...
Milestone Pharmaceuticals has announced new data showing that its Cardamyst (etripamil) nasal spray converted approximately two-thirds of patients who experienced recurrent symptomatic paroxysmal supraventricular tachycardia...